Attending the upcoming European Society of Human Genetics (ESHG) virtual conference? Please join us for this live Corporate Satellite Meeting:
Monday, August 30th, 15.30 – 16.30 CEST
In this session you will discover how two scientists have streamlined their laboratory workflow using OGT’s next generation sequencing (NGS) panels, allowing them to accurately detect a wide variety of genetic aberrations.
Elizabeth McCready, PhD, FCCMG
Hamilton Regional Laboratory Medicine Program; Associate Professor, McMaster University
"Clinical evaluation of an NGS-based assay for the detection of CNV and SNV acting synergistically to affect phenotype."
Fléchère Fortin, PhD, FCCMG
Scientific Director, Cytogenetics laboratory, Medical Genetics Division, CIUSSS de l’Estrie-CHUS
"Genetic evaluation of CLL: transitioning from a SNP-array CGH platform to an NGS-based CNV+SNV approach."